UPDATE: Deutsche Bank Starts Boston Scientific (BSX) at Hold

Deutsche Bank analyst Pito Chickering initiates coverage on Boston Scientific (NYSE: BSX) with a Hold rating and a price target of $39.00.

The analyst comments "While we like the 2022+ story and beyond, the setbacks seen during 2020 have made us cautious on BSX and we look for the broader cardio markets to rebound and execution to improve before we get more constructive on the name. While we are cautious on the name in the near-term, we believe investors will appreciate that our data can now map almost all of BSX’s US segments very well and can provide insights on the growth of key product categories. Boston Scientific has made significant progress on multiple fronts over the past few years."

For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.

Shares of Boston Scientific closed at $35.56 yesterday.

You May Also Be Interested In

• UPDATE: Atlantic Equities Starts Boston Scientific (BSX) at Overweight
• Zhuzhou CRRC Times Electric Co., Ltd (3898:HK) (ZHUZY) PT Lowered to HK$53.80 at JPMorgan
• New Oriental Education & Technology Group (9901:HK) PT Lowered to HK$145 at JPMorgan